Cancer Crosslinks 2016
The Transversal Impact of New Treatments in Oncology and Hematology:
Tumor Microenvironment, Novel Concepts, Combinations and Study Design
Tumor Microenvironment, Novel Concepts, Combinations and Study Design
Event 2016 - Speakers & Topics
Gordon J. Freeman, Division of Hematologic Malignancies, Department of Medical Oncology; Dana-Farber Cancer Institute & Harvard Medical School, Boston, USA
- PD-1 Cancer Immunotherapy
Åslaug Helland, Senior Oncologist, Dept. of Oncology, Oslo University Hospital and Group leader, Institute for Cancer Research Oslo University Hospital
- Case Study: Immunotherapy in NSCLC
Alexander Fosså, Senior Oncologist, Dept. of Oncology, Oslo University Hospital
- Case Study: PD-1 in Lymphoma
Renier Brentjens, MD, PhD; Chief, Cellular Therapeutics Center & Associate Professor Memorial Sloan-Kettering Cancer Center; New York, USA
- CAR T-cell Treatment of B-Cell Malignancies – With an Overview of Current Treatment Options in Leukemia
Stefani Spranger, Department of Pathology, The Ben May Department for Cancer Research, University of Chicago, USA
- The Role of the T cell-inflamed and non-T cell-inflamed Tumor Microenvironment for Immunotherapy
A complete program for Cancer Crosslinks 2016 may be downloaded HERE.
Event 2016 - Sponsors
|
|